Navigation
Navigation

Capricorn Health-tech Fund

The Capricorn Health-tech Fund (CHF) focuses on human health-technology investments. Health-technologies relate to the prevention, the diagnosis and the treatment of diseases.

iSTAR Medical announces € 40 million Series C financing

News
- 05/09/2019
To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM Wavre, Belgium: 5 September 2019 —iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced…
Read more

Capricorn Venture Partners renamed to Capricorn Partners

News
- 30/08/2019
Leuven, Belgium: 30 August 2019 - As of today, Capricorn Partners is the new name of Capricorn Venture Partners. Capricorn Partners reflects better some recent changes in the structure of the company and the broader…
Read more

Team
Dr Jos B. Peeters
Chairman of the Executive Committee - Responsible for venture capital, finance and IT
Dr Katya Smirnyagina
Executive Director Capricorn Health-tech Fund

Portfolio

Success stories

Ogeda

Ogeda [Belgium] is a drug development company with a chemistry service business focusing on discovery of small molecules targeting GPCRs.